Bandingkan Harga & Kinerja Enseval Putera Megatrading Tbk. (EPMT) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Enseval Putera Megatrading Tbk. dan Organon Pharma Indonesia Tbk.: Enseval Putera Megatrading Tbk. diperdagangkan di Rp2.540 (kapitalisasi pasar 6,47 T, volume 24 jam 761,1 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Enseval Putera Megatrading Tbk. jauh lebih besar — sekitar 62× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| EPMT | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 6,47 T | 104,4 M |
Volume | 761,1 rb | — |
Lot | 7,61 rb | — |
Perputaran | 1,99 M | — |
Harga Rata-rata | 2.611 | — |
Nilai Transaksi | 1,99 M | — |
Harga Ekuilibrium Indikatif | 2.540 | — |
Volume Ekuilibrium Indikatif | 65 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Enseval Putera Megatrading Tbk.
PT. Enseval Putera Megatrading Tbk, formerly PT Arya Gupta Cempaka, was established based on deed No. 64 dated October 26, 1998 of Mrs. Rukmasanti Hardjasatya,SH, notary public in Jakarta. The company’s articles of association have been amended several times, most recently by deed No. 200 dated June 30, 1997 of Mrs. Poerbaningsih Adi Warsito, SH, notary public in Jakarta, concerning the changes of the company’s articles of association to comply with Corporate Law no. 1 year 1995, the increase in the company’s authorized capital and the change in par value per share from Rp 1,000 to Rp 500.
Selengkapnya di halaman EPMT →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
